Preclinical 203/212Pb-DOTA-Based Pretargeted Radioimmunotherapy in Nude Mice Bearing Established Human Colorectal Cancer Xenografts.
Saved in:
| Title: | Preclinical 203/212Pb-DOTA-Based Pretargeted Radioimmunotherapy in Nude Mice Bearing Established Human Colorectal Cancer Xenografts. |
|---|---|
| Authors: | Vaughn BA; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Veach DR; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiology, Weill Cornell Medicine, New York, New York., Vargas DB; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Seo S; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Punzalan B; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Rinne SS; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Fung EK; Department of Medical Physics, Weill Cornell Medicine, New York, New York., Xu H; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Guo HF; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Yang G; Organic Synthesis Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York; and., Ouerfelli O; Organic Synthesis Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York; and., Carrasco SE; Laboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine and Rockefeller University, New York, New York., St Jean S; Laboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine and Rockefeller University, New York, New York., Cheung NV; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Larson SM; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Cheal SM; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York; smc4002@med.cornell.edu.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 May 01; Vol. 67 (5), pp. 700-708. Date of Electronic Publication: 2026 May 01. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1535-5667 |
|---|---|
| DOI: | 10.2967/jnumed.125.270604 |
